Citation: | ZHOU Mei-yu, YUAN Shuai, XIANG Ying, WU Long, WU Na, LI Cheng-ying, XU Bin, ZHANG Yao, CAI Tong-jian, MA Xiang-yu, YU Zu-bin, BAI Li, YANG Jing-yuan, LI Ya-fei. Expression and cellular function of long non-coding RNA SFTA1P in non-small cell lung cancer[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(3): 341-347. doi: 10.16462/j.cnki.zhjbkz.2020.03.018 |
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
|
[2] |
Brainard J, Farver C. The diagnosis of non-small cell lung cancer in the molecular era[J]. Mod Pathol, 2019, 32(Suppl 1): 16-26. DOI: 10.1038/s41379-018-0156-x.
|
[3] |
Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development[J]. Nat Rev Genet, 2014, 15(1): 7-21. DOI: 10.1038/nrg3606.
|
[4] |
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet, 2016, 17(1): 47-62. DOI: 10.1038/nrg.2015.10.
|
[5] |
Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world[J]. Oncotarget, 2014, 5(22): 10976-10996. DOI: 10.18632/oncotarget.2770.
|
[6] |
Melissari MT, Grote P. Roles for long non-coding RNAs in physiology and disease[J]. Pflugers Arch, 2016, 468(6): 945-958. DOI: 10.1007/s00424-016-1804-y.
|
[7] |
Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer[J]. Oncotarget, 2014, 5(18): 8027-8038. DOI: 10.18632/oncotarget.2469.
|
[8] |
Ma H, Ma T, Chen M, et al. The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer[J]. Biosci Rep, 2018, 38(2)pii: BSR20171193. DOI: 10.1042/BSR20171193.
|
[9] |
Wei MM, Zhou GB. Long non-coding RNAs and their roles in non-small-cell lung cancer[J]. Genomics Proteomics Bioinformatics, 2016, 14(5): 280-288. DOI: 10.1016/j.gpb.2016.03.007.
|
[10] |
Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs[J]. Cell, 2009, 136(4): 629-641. DOI: 10.1016/j.cell.2009.02.006.
|
[11] |
Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future[J]. Genetics, 2013, 193(3): 651-669. DOI: 10.1534/genetics.112.146704.
|
[12] |
Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals[J]. Nature, 2009, 458(7235): 223-227. DOI: 10.1038/nature07672.
|
[13] |
Volders PJ, Verheggen K, Menschaert G, et al. An update on LNCipedia: a database for annotated human lncRNA sequences[J]. Nucleic Acids Res, 2015, 43(8): 4363-4364. DOI: 10.1093/nar/gkv295.
|
[14] |
Luo J, Tang L, Zhang J, et al. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer[J]. Tumour Biol, 2014, 35(11): 11541-11549. DOI: 10.1007/s13277-014-2442-7.
|
[15] |
Liu XH, Liu ZL, Sun M, et al. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer[J]. BMC Cancer, 2013, 13: 464. DOI: 10.1186/1471-2407-13-464.
|
[16] |
Shen L, Chen L, Wang Y, et al. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer[J]. J Neurooncol, 2015, 121(1): 101-108. DOI: 10.1007/s11060-014-1613-0.
|
[17] |
Zhang EB, Yin DD, Sun M, et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression[J]. Cell Death Dis, 2014, 5: e1243. DOI: 10.1038/cddis.2014.201.
|
[18] |
Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression[J]. BMC Cancer, 2013, 13: 461. DOI: 10.1186/1471-2407-13-461.
|
[19] |
Sun M, Liu XH, Lu KH, et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition[J]. Cell Death Dis, 2014, 5: e1298. DOI: 10.1038/cddis.2014.256.
|
[20] |
Tano K, Mizuno R, Okada T, et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes[J]. FEBS Lett, 2010, 584(22): 4575-4580. DOI: 10.1016/j.febslet.2010.10.008.
|
[21] |
Zou Y, Zhang B, Mao Y, et al. Long non-coding RNA OECC promotes cell proliferation and metastasis through the PI3K/Akt/mTOR signaling pathway in human lung cancer[J]. Oncol Lett, 2019, 18(3): 3017-3024. DOI: 10.3892/ol.2019.10644.
|
[22] |
Sun Z, He C, Xiao M, et al. LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15[J]. Am J Transl Res, 2019, 11(7): 4552-4560. http://www.researchgate.net/publication/335100039_LncRNA_FOXC2_antisense_transcript_accelerates_non-small-cell_lung_cancer_tumorigenesis_via_silencing_p15
|
[23] |
Li W, Sun M, Zang C, et al. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells[J]. Cell Death Dis, 2016, 7: e2225. DOI: 10.1038/cddis.2016.126.
|
[24] |
Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease[J]. Cell, 2013, 152(6): 1298-1307. DOI: 10.1016/j.cell.2013.02.012.
|
[25] |
Takahashi K, Yan I, Haga H, et al. Long noncoding RNA in liver diseases[J]. Hepatology, 2014, 60(2): 744-753. DOI: 10.1002/hep.27043.
|
[26] |
Villegas VE, Zaphiropoulos PG. Neighboring gene regulation by antisense long non-coding RNAs[J]. Int J Mol Sci, 2015, 16(2): 3251-3266. DOI: 10.3390/ijms16023251.
|
[27] |
Zhu SP, Wang JY, Wang XG, et al. Long intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer[J]. Aging(Albany NY), 2017, 9(2): 475-486. DOI: 10.18632/aging.101171.
|
[28] |
Zheng J, Zhang H, Ma R, et al. Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-kappaB pathway in gastric cancer[J]. Oncogene, 2019, 38(45): 7073-7088. DOI: 10.1038/s41388-019-0934-z.
|